-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, UhLoAgIaceuIG9NH6GPWzPW1WhjqIfuGnBIVb0Ty2/9QZWU9wD0UBDP5Dc0Ff6ds C1YZ5Y1ZJeL26r+pxXGSvQ== 0001144204-03-006419.txt : 20031023 0001144204-03-006419.hdr.sgml : 20031023 20031023120725 ACCESSION NUMBER: 0001144204-03-006419 CONFORMED SUBMISSION TYPE: SC 13D/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20031023 GROUP MEMBERS: BRUCE J. HABER GROUP MEMBERS: ROYCE KANOFSKY SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: MOORE MEDICAL CORP CENTRAL INDEX KEY: 0000074691 STANDARD INDUSTRIAL CLASSIFICATION: WHOLESALE-MEDICAL, DENTAL & HOSPITAL EQUIPMENT & SUPPLIES [5047] IRS NUMBER: 221897821 STATE OF INCORPORATION: DE FISCAL YEAR END: 0102 FILING VALUES: FORM TYPE: SC 13D/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-07421 FILM NUMBER: 03953463 BUSINESS ADDRESS: STREET 1: PO BOX 1500 STREET 2: 389 JOHN DOWNEY DR CITY: NEW BRITAIN STATE: CT ZIP: 06050 BUSINESS PHONE: 2038263600 MAIL ADDRESS: STREET 1: 389 JOHN DOWNEY DRIVE CITY: NEW BRITAIN STATE: CT ZIP: 06050 FORMER COMPANY: FORMER CONFORMED NAME: OPTEL CORP DATE OF NAME CHANGE: 19850611 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: FHS ENTERPRISES LLC CENTRAL INDEX KEY: 0001136503 FILING VALUES: FORM TYPE: SC 13D/A BUSINESS ADDRESS: STREET 1: 145 HUGUENOT STREET SUITE 402 CITY: NEW ROCHELLE STATE: NY ZIP: 10801 BUSINESS PHONE: 9142355550 MAIL ADDRESS: STREET 1: 145 HUGUENOT STREET SUITE 402 CITY: NEW ROCHELLE STATE: NY ZIP: 10801 SC 13D/A 1 sched13d.txt SCHEDULE 13D Page 1 of 9 SEC POTENTIAL PERSONS WHO ARE TO RESPOND TO THE COLLECTION OF INFORMATION 1746 CONTAINED IN THIS FORM ARE NOT REQUIRED TO RESPOND UNLESS THE FORM (2-98) DISPLAYS A CURRENTLY VALID OMB CONTROL NUMBER. UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13D UNDER THE SECURITIES EXCHANGE ACT OF 1934 (AMENDMENT NO. 2)* Moore Medical Corp. (Name of Issuer) Common Stock, $.01 Par Value (Title of Class of Securities) 615799103 (CUSIP Number) David Selangut, Esq. c/o Ellenoff Grossman & Schole LLP 370 Lexington Avenue, New York, NY 10017 (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications) October 20, 2003 (Date of Event which Requires Filing of this Statement) If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of Sections 240.13d-1(e), 240.13d-1(F) or 240.13d-1(g), check the following box. [ ] NOTE: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See Section 240.13d-7 for other parties to whom copies are to be sent. * The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page. The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). SCHEDULE 13D CUSIP NO. 615799103 PAGE 2 OF 9 - -------------------------------------------------------------------------------- 1 NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NOs. OF ABOVE PERSONS (ENTITIES ONLY) Bruce J. Haber - -------------------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions) X (a) / / (b) / / - -------------------------------------------------------------------------------- 3 SEC USE ONLY - -------------------------------------------------------------------------------- 4 SOURCE OF FUNDS (SEE INSTRUCTIONS) PF - -------------------------------------------------------------------------------- 5 CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e) / / - -------------------------------------------------------------------------------- 6 CITIZENSHIP OR PLACE OF ORGANIZATION United States - -------------------------------------------------------------------------------- 7 SOLE VOTING POWER NUMBER OF SHARES 93,950 BENEFICIALLY ----------------------------------------------------------------- OWNED BY 8 SHARED VOTING POWER EACH REPORTING 17,500 PERSON ----------------------------------------------------------------- WITH 9 SOLE DISPOSITIVE POWER 93,950 ----------------------------------------------------------------- 10 SHARED DISPOSITIVE POWER 17,500 - -------------------------------------------------------------------------------- 11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 111,450 - -------------------------------------------------------------------------------- 12 CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) / / - -------------------------------------------------------------------------------- 13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 3.5% - -------------------------------------------------------------------------------- 14 TYPE OF REPORTING PERSON (See Instructions) IN - -------------------------------------------------------------------------------- SCHEDULE 13D CUSIP NO. 615799103 PAGE 2 OF 9 - -------------------------------------------------------------------------------- 1 NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NOs. OF ABOVE PERSONS (ENTITIES ONLY) Royce Kanofsky - -------------------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions) X (a) / / (b) / / - -------------------------------------------------------------------------------- 3 SEC USE ONLY - -------------------------------------------------------------------------------- 4 SOURCE OF FUNDS (SEE INSTRUCTIONS) PF - -------------------------------------------------------------------------------- 5 CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e) / / - -------------------------------------------------------------------------------- 6 CITIZENSHIP OR PLACE OF ORGANIZATION United States - -------------------------------------------------------------------------------- 7 SOLE VOTING POWER NUMBER OF SHARES 102,100 BENEFICIALLY ----------------------------------------------------------------- OWNED BY 8 SHARED VOTING POWER EACH REPORTING 500 PERSON ----------------------------------------------------------------- WITH 9 SOLE DISPOSITIVE POWER 102,100 ----------------------------------------------------------------- 10 SHARED DISPOSITIVE POWER 500 - -------------------------------------------------------------------------------- 11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 102,600 - -------------------------------------------------------------------------------- 12 CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) / / - -------------------------------------------------------------------------------- 13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 3.2% - -------------------------------------------------------------------------------- 14 TYPE OF REPORTING PERSON (See Instructions) IN - -------------------------------------------------------------------------------- SCHEDULE 13D CUSIP NO. 615799103 PAGE 2 OF 9 - -------------------------------------------------------------------------------- 1 NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NOs. OF ABOVE PERSONS (ENTITIES ONLY) FHS Enterprises LLC - -------------------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions) X (a) / / (b) / / - -------------------------------------------------------------------------------- 3 SEC USE ONLY - -------------------------------------------------------------------------------- 4 SOURCE OF FUNDS (SEE INSTRUCTIONS) WC - -------------------------------------------------------------------------------- 5 CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e) / / - -------------------------------------------------------------------------------- 6 CITIZENSHIP OR PLACE OF ORGANIZATION New York - -------------------------------------------------------------------------------- 7 SOLE VOTING POWER NUMBER OF SHARES 500 BENEFICIALLY ----------------------------------------------------------------- OWNED BY 8 SHARED VOTING POWER EACH REPORTING PERSON ----------------------------------------------------------------- WITH 9 SOLE DISPOSITIVE POWER 500 ----------------------------------------------------------------- 10 SHARED DISPOSITIVE POWER - -------------------------------------------------------------------------------- 11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 500 - -------------------------------------------------------------------------------- 12 CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) / / - -------------------------------------------------------------------------------- 13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 0.02% - -------------------------------------------------------------------------------- 14 TYPE OF REPORTING PERSON (See Instructions) CO - -------------------------------------------------------------------------------- Item 1 Security and Issuer 1) Common Stock, $0.01 par value (the "Shares") Moore Medical Corp. (the "Issuer") P.O. Box 1500 389 John Downey Drive New Britain, CT 06050 Item 2 Identity and Background Item 2 is hereby amended and replaced with the following Item 2. 1. a) Bruce J. Haber b) 65 The Oaks Roslyn, NY 11576 c) President of BJH Management, LLC d-e) There has been no convictions, proceedings or securities violations in the past 5 years. f) U.S. Citizen 2. a) Royce Kanofsky b) 1665 Warwick Road Hewlett, NY 11557 c) Investment Banking d-e) There has been no convictions, proceedings or securities violations in the past 5 years. f) U.S. Citizen 3. a) FHS Enterprises LLC ("FHS") b) 145 Huguenot Street, Suite 402 New Rochelle, NY 10801 Mr. Haber and Mr. Kanofsky are both members of FHS. c) FHS Enterprises LLC was organized to acquire and hold securities. d-e) N/A f) FHS Enterprises LLC is a New York Limited Liability Company organized on February 21, 2001 The aforementioned parties together will be referred to as the "Reporting Parties." Item 3 Source and Amount of Funds or Other Consideration Item 3 is hereby amended and replaced with the following Item 3: 1. The shares of common stock were purchased with personal funds of the Reporting Parties. Item 5 Interest in Securities of the Issuer Item 5 is hereby amended and replaced with the following Item 5: 1. Bruce J. Haber a-b) Mr. Bruce J. Haber may be deemed to beneficially own 111,450 shares of the Common Stock, which constitutes approximately 3.5% of the outstanding shares of Common Stock (based on the 3,189,784 shares of Common Stock outstanding as of July 26, 2003 as reported on the June 28, 2003 Quarterly Report on Form 10-Q. Of these shares: i) 93,950 shares of Common Stock are owned directly by Mr. Haber. ii) 12,000 shares are owned by his wife, Mr. Haber disclaims beneficial ownership of the shares held by his wife. iii) 5,000 shares are owned in a trust in favor of his daughter in which Mrs. Haber is the trustee. iv) 500 shares are attributed to Mr. Haber by virtue of his part ownership of FHS. c) Mr. Bruce J. Haber purchased 6,600 shares in the past 60 days at prices between $5.75 and $6.20 per share. Mr. Haber, Mr. Kanofsky and FHS, as a group beneficially own approximately 6.7% of the Company's shares of Common Stock. 2. Royce Kanofsky a-b) Mr. Royce Kanofsky beneficially owns 102,600 shares of the Common Stock, which constitutes approximately 3.2% of the outstanding shares of Common Stock. Of these shares, 102,100 are owned directly by Mr. Kanofsky and 500 shares are attributed to him by virtue of his part ownership of FHS. c) Mr. Royce Kanofsky purchased 8,500 shares within the past 60 days at prices between $5.75 and $6.20 per share. Mr. Haber, Mr. Kanofsky and FHS, as a group beneficially own 6.7% of the Company's shares of Common Stock. 3. FHS a-b) FHS beneficially owns 500 shares of the Common Stock, which constitutes approximately 0.02% of the outstanding shares of Common Stock. Exhibit A - Agreement: Joint Filing of Schedule 13D After reasonable inquiry and to the best of our knowledge and belief, we certify that the information set forth in this statement is true, complete and correct. Date: October 20, 2003 FHS Enterprises LLC By: /s/ Bruce J. Haber ------------------ Bruce J. Haber President /s/ Bruce J. Haber ------------------ Bruce J. Haber /s/ Royce Kanofsky ------------------ Royce Kanofsky EXHIBIT A AGREEMENT JOINT FILING OF SCHEDULE 13D The undersigned hereby agree to jointly prepare and file with the regulatory authorities a Schedule 13D and any future amendments thereto reporting each or the undersign's ownership of securities of Moore Medical Corporation, and hereby affirm that such Schedule 13D is being filled on behalf of each of them. FHS Enterprises LLC Date: October 20, 2003 By: /s/ Bruce J. Haber New York, NY Bruce J. Haber President Date: October 20, 2003 /s/ Bruce J. Haber New York, NY Bruce J. Haber Date: October 20, 2003 /s/ Royce Kanofsky New York, NY Royce Kanofsky -----END PRIVACY-ENHANCED MESSAGE-----